144 related articles for article (PubMed ID: 36738485)
1. Impact of racial disparities on potential years of life lost due to gynecologic cancer in the United States: Trends from 1975 to 2017 based on SEER database.
Kaur A; Wang S; Kumar A
Gynecol Oncol; 2023 Mar; 170():266-272. PubMed ID: 36738485
[TBL] [Abstract][Full Text] [Related]
2. Enrollment of Individuals From Racial and Ethnic Minority Groups in Gynecologic Cancer Precision Oncology Trials.
Mattei LH; Robb L; Banning K; Polan RM; Cote ML
Obstet Gynecol; 2022 Oct; 140(4):654-661. PubMed ID: 36075065
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ
Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352
[TBL] [Abstract][Full Text] [Related]
4. Update of HPV-associated female genital cancers in the United States, 1999-2004.
Watson M; Saraiya M; Wu X
J Womens Health (Larchmt); 2009 Nov; 18(11):1731-8. PubMed ID: 19951205
[TBL] [Abstract][Full Text] [Related]
5. The generalizability of NCI-sponsored clinical trials accrual among women with gynecologic malignancies.
Mishkin G; Minasian LM; Kohn EC; Noone AM; Temkin SM
Gynecol Oncol; 2016 Dec; 143(3):611-616. PubMed ID: 27697287
[TBL] [Abstract][Full Text] [Related]
6. Racial and ethnic differences in early death among gynecologic malignancy.
Lee MW; Vallejo A; Furey KB; Woll SM; Klar M; Roman LD; Wright JD; Matsuo K
Am J Obstet Gynecol; 2024 Mar; ():. PubMed ID: 38460831
[TBL] [Abstract][Full Text] [Related]
7. Person-years of life lost and lost earnings from cigarette smoking-attributable cancer deaths, United States, 2019.
Islami F; Marlow EC; Zhao J; Wiese D; Asare S; Bandi P; Thomson B; Zheng Z; Nargis N; Yabroff KR; Jemal A
Int J Cancer; 2022 Dec; 151(12):2095-2106. PubMed ID: 35946832
[TBL] [Abstract][Full Text] [Related]
8. Racial and ethnic disparities in palliative care utilization among gynecological cancer patients.
Islam JY; Deveaux A; Previs RA; Akinyemiju T
Gynecol Oncol; 2021 Feb; 160(2):469-476. PubMed ID: 33276985
[TBL] [Abstract][Full Text] [Related]
9. Racial and ethnic disparities over time in the treatment and mortality of women with gynecological malignancies.
Rauh-Hain JA; Melamed A; Schaps D; Bregar AJ; Spencer R; Schorge JO; Rice LW; Del Carmen MG
Gynecol Oncol; 2018 Apr; 149(1):4-11. PubMed ID: 29605048
[TBL] [Abstract][Full Text] [Related]
10. Gynecologic malignancies in women aged less than 25 years.
You W; Dainty LA; Rose GS; Krivak T; McHale MT; Olsen CH; Elkas JC
Obstet Gynecol; 2005 Jun; 105(6):1405-9. PubMed ID: 15932836
[TBL] [Abstract][Full Text] [Related]
11. Gynecologic cancer outcomes in the elderly poor: A population-based study.
Doll KM; Meng K; Basch EM; Gehrig PA; Brewster WR; Meyer AM
Cancer; 2015 Oct; 121(20):3591-9. PubMed ID: 26230631
[TBL] [Abstract][Full Text] [Related]
12. Healthcare resource use and costs associated with cervical, vaginal and vulvar cancers in a large U.S. health plan.
Insinga RP; Ye X; Singhal PK; Carides GW
Gynecol Oncol; 2008 Nov; 111(2):188-96. PubMed ID: 18757080
[TBL] [Abstract][Full Text] [Related]
13. Racial disparities in palliative care utilization among metastatic gynecological cancer patients living at last follow-up: An analysis of the National Cancer Data Base.
Islam JY; Deveaux A; Previs RA; Akinyemiju T
Data Brief; 2021 Feb; 34():106705. PubMed ID: 33473361
[TBL] [Abstract][Full Text] [Related]
14. Premature mortality due to cancer in Swietokrzyskie Province (Poland) in 1999-2010.
Gózdz S; Krzyzak M; Maślach D; Kolpak M; Wróbel M; Bielska-Lasota M
Przegl Epidemiol; 2013; 67(3):477-82, 575-9. PubMed ID: 24340564
[TBL] [Abstract][Full Text] [Related]
15. Trends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019: Cervical, ovarian and uterine cancer.
Wang Z; Guo E; Yang B; Xiao R; Lu F; You L; Chen G
Gynecol Oncol; 2021 Nov; 163(2):358-363. PubMed ID: 34507827
[TBL] [Abstract][Full Text] [Related]
16. Mortality trend in a rapidly developing economy in Taiwan. Part II: Life expectancy and "potential years of life lost".
Tsai SP; Wen CP; Guo JP; Tsai SF
Asia Pac J Public Health; 1991; 5(1):49-53. PubMed ID: 1799532
[TBL] [Abstract][Full Text] [Related]
17. Disparities in the allocation of research funding to gynecologic cancers by Funding to Lethality scores.
Spencer RJ; Rice LW; Ye C; Woo K; Uppal S
Gynecol Oncol; 2019 Jan; 152(1):106-111. PubMed ID: 30404721
[TBL] [Abstract][Full Text] [Related]
18. Outcome of patients with local recurrent gynecologic malignancies after resection combined with intraoperative electron radiation therapy (IOERT).
Arians N; Foerster R; Rom J; Uhl M; Roeder F; Debus J; Lindel K
Radiat Oncol; 2016 Mar; 11():44. PubMed ID: 26988089
[TBL] [Abstract][Full Text] [Related]
19. Racial-Ethnic Comparison of Guideline-Adherent Gynecologic Cancer Care in an Equal-Access System.
Eaglehouse YL; Darcy KM; Tian C; Casablanca Y; Shriver CD; Zhu K
Obstet Gynecol; 2021 Apr; 137(4):629-640. PubMed ID: 33706355
[TBL] [Abstract][Full Text] [Related]
20. Potential years of life lost to cancer in Mato Grosso, stratified by sex: 2000 to 2019.
Galvão SM; Atanaka M; Sousa NFDS; Galvão ND
Rev Bras Epidemiol; 2022; 25(Supl 1):e220009. PubMed ID: 35766766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
